RxDoctor Payments Data

Cybill Thomas, APRN

Family · Waterbury, CTNPI 1285821603

Payments from drug & device makers

$2,863in general payments, 2019–2025

Across 137 payments — averaging $20.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$535
  • Takeda Pharmaceuticals U.S.A., Inc.$498
  • Johnson & Johnson$219
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$198
  • Bristol Myers Squibb$147
  • Ironwood Pharmaceuticals, Inc$137
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,77797%
  • Education$863%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,863 in reported general payments places this provider in the 85th percentile of 1,596 family providers in Connecticut.

See all family providers in Connecticut

Medicare billing

Part B allowed, 2024
$17,311
Medicare patients
183
Services billed
232

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide52$35,427
ZenpepLipase/Protease/Amylase16$27,099
Dexlansoprazole DrDexlansoprazole15$5,335
Lansoprazole23$4,918
Famotidine76$1,748
Omeprazole106$1,651
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates29$1,583
Pantoprazole Sodium110$1,503
CholestyramineCholestyramine (With Sugar)11$1,459
Sucralfate18$601
Esomeprazole Magnesium25$595
LoperamideLoperamide Hcl13$185
Dicyclomine Hcl17$173

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$535$35,42752 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,596 family providers in Connecticut.

Other family in Waterbury

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →